In conclusion, we investigated the effects of WEE1 and ATR inhibitors, alone and in combination, on U2OS osteosarcoma cells and on a panel of four lung cancer cell lines with different sensitivities to the WEE1 inhibitor. The gene discussed is WEE1; the disease is lung cancer.